Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin Regimens for Strongyloides Stercoralis Infection
NCT03605758Phase 3Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- May 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ivermectin in strongyloidiasis, sponsored by Albert Einstein College of Medicine. Started May 2012; status: terminated.
02
Drugs
ivermectin
03
Conditions
strongyloidiasis
Beyond the preview
Go deeper on NCT03605758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03605758.